In Brief Alice Lin Pomponio named SVP of corporate development and strategic partnerships at PICI March 27, 2026Vol.52 No.12
Clinical Roundup Talzenna + Xtandi significantly improves radiographic PFS in metastatic prostate cancer March 27, 2026Vol.52 No.12
Clinical Roundup Combination treatment benefits patients with leptomeningeal metastases from breast cancer, MD Anderson study finds March 27, 2026Vol.52 No.12
Clinical Roundup Mayo Clinic pilot study demonstrates safety, feasibility of delivering chemotherapy at home March 27, 2026Vol.52 No.12
Clinical Roundup VCU Massey researchers lead international effort to produce multi-omic digital atlas of oral tissues March 27, 2026Vol.52 No.12
Clinical Roundup Researchers “turbocharge” immune cells to attack prostate cancer March 27, 2026Vol.52 No.12
Clinical Roundup Dual-targeting approach improves immunotherapy response in glioblastoma, MD Anderson study finds March 27, 2026Vol.52 No.12
Clinical Roundup GPSai AI algorithm may help identify and correct misdiagnoses of cancer March 27, 2026Vol.52 No.12
Drugs & Targets FDA and EC approve Opdivo IO combinations in classical Hodgkin Lymphoma March 27, 2026Vol.52 No.12
Drugs & Targets FDA approves relacorilant + nab-paclitaxel for platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer March 27, 2026Vol.52 No.12